For activation of STAT3 both EGFR mediated signaling as well as IL-6 signaling has been shown to be relevant and in NSCLC tumor cells JAK1 and not JAK2 was determined as the signal relaying kinase [82]. This evidence concerns the gene STAT3 and neoplasm.